Drugs Used in TB and Leprosy

Meenakshi R. Ramanathan, James M. Sanders

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.

Original languageEnglish
Title of host publicationSide Effects of Drugs Annual
PublisherElsevier B.V.
Pages283-293
Number of pages11
DOIs
StatePublished - 1 Jan 2017

Publication series

NameSide Effects of Drugs Annual
Volume39
ISSN (Print)0378-6080

    Fingerprint

Keywords

  • Adverse effects
  • Ethambutol
  • Isoniazid
  • Leprosy
  • Pyrazinamide
  • Rifamycins
  • Side effects
  • Tuberculosis

Cite this

Ramanathan, M. R., & Sanders, J. M. (2017). Drugs Used in TB and Leprosy. In Side Effects of Drugs Annual (pp. 283-293). (Side Effects of Drugs Annual; Vol. 39). Elsevier B.V.. https://doi.org/10.1016/bs.seda.2017.06.025